Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Apply
Temozolomide & Atezolizumab
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step